![Suzanne Roghieh Saffie-Siebert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Suzanne Roghieh Saffie-Siebert
Chief Executive Officer at SiSaf Ltd.
Profile
Suzanne Roghieh Saffie-Siebert has founded two companies.
SiSaf Ltd.
was founded in 2006, where she holds the title of Chief Executive Officer.
Autism Biotech Ltd.
was founded in 2012, where she also held the title of Chief Executive Officer.
Dr. Saffie-Siebert's former jobs include being a Research Director at pSiMedica Ltd.
and Head-Drug Delivery Centre at Dompé SpA.
Dr. Saffie-Siebert earned a doctorate degree from the University of London.
Suzanne Roghieh Saffie-Siebert active positions
Companies | Position | Start |
---|---|---|
SiSaf Ltd.
![]() SiSaf Ltd. BiotechnologyHealth Technology SiSaf Ltd. engages in the design and formulation of drugs for topical delivery systems. Its proprietary technology represents a highly effective, non-irritant carrier for cosmetic and medical products, where improved skin penetration, targeting, and controlled release are required. The firm uses nanosilicon as a carrier for active compounds allowing them to penetrate deep beneath the skin's epidermal barrier for controlled release. It operates through its offices located in Belfast and San Jose. The company was founded by Suzanne Roghieh Saffie-Siebert and Timothy John Brundle in 2006 and is headquartered in Belfast, the United Kingdom. | Chief Executive Officer | 22/09/2011 |
Former positions of Suzanne Roghieh Saffie-Siebert
Companies | Position | End |
---|---|---|
Dompé SpA
![]() Dompé SpA Pharmaceuticals: MajorHealth Technology Dompé SpA provides services of updating and scientific assistance to doctors. It offers information on therapeutic areas including physiatrics, cystic fibrosis, geriatrics, infectious diseases, internal, sleep and sports medicine, odontology, orthopedics and traumatology, otorhinolaryngology, pediatrics, pneumology, and emergency and drugs. The company was founded by Sergio Dompé in 1993 and is headquartered in L'Aquila, Italy. | Corporate Officer/Principal | - |
Autism Biotech Ltd.
![]() Autism Biotech Ltd. BiotechnologyHealth Technology Autism Biotech Ltd. researches and develops biotechnology. The company was founded by Suzanne Roghieh Saffie-Siebert in 2012 and is headquartered in Queens Island, the United Kingdom. | Chief Executive Officer | - |
pSiMedica Ltd.
![]() pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Chief Tech/Sci/R&D Officer | - |
Training of Suzanne Roghieh Saffie-Siebert
University of London | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
pSiMedica Ltd.
![]() pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Commercial Services |
Dompé SpA
![]() Dompé SpA Pharmaceuticals: MajorHealth Technology Dompé SpA provides services of updating and scientific assistance to doctors. It offers information on therapeutic areas including physiatrics, cystic fibrosis, geriatrics, infectious diseases, internal, sleep and sports medicine, odontology, orthopedics and traumatology, otorhinolaryngology, pediatrics, pneumology, and emergency and drugs. The company was founded by Sergio Dompé in 1993 and is headquartered in L'Aquila, Italy. | Health Technology |
SiSaf Ltd.
![]() SiSaf Ltd. BiotechnologyHealth Technology SiSaf Ltd. engages in the design and formulation of drugs for topical delivery systems. Its proprietary technology represents a highly effective, non-irritant carrier for cosmetic and medical products, where improved skin penetration, targeting, and controlled release are required. The firm uses nanosilicon as a carrier for active compounds allowing them to penetrate deep beneath the skin's epidermal barrier for controlled release. It operates through its offices located in Belfast and San Jose. The company was founded by Suzanne Roghieh Saffie-Siebert and Timothy John Brundle in 2006 and is headquartered in Belfast, the United Kingdom. | Health Technology |
Autism Biotech Ltd.
![]() Autism Biotech Ltd. BiotechnologyHealth Technology Autism Biotech Ltd. researches and develops biotechnology. The company was founded by Suzanne Roghieh Saffie-Siebert in 2012 and is headquartered in Queens Island, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Suzanne Roghieh Saffie-Siebert